TVL(TM) LEAD SYSTEM
ABBOTT MEDICAL · Decision date May 10, 1996
What did the FDA approve?
The FDA recorded approval of P950022, the Ventritex TVL Lead System, on 1996-05-10 under product code LWS in the cardiovascular specialty, with Abbott Medical listed as applicant. The recorded scope covers transvenous right ventricular leads (RV-1101, RV01, RV02), transvenous superior vena cava leads (SV-1101, SV01, SV02, SV03), subcutaneous leads (SQ-701, SQ01), a vein pick (TV-0001), silicone lubricant (TV-0013), a lead tunneler kit (LTK-01), a high voltage Y-adapter (AC-2481), an external stimulator adapter (AC-CDT-EX), and an accessory kit.
This is an original approval rather than a supplement, so the record describes the lead system and its accessories as a category; patient-selection criteria and treatment instructions are not part of the source data and remain in the original FDA document. The record does not state current labeling, post-market findings, or the basis for the decision.
FDA approval order statement
APPROVAL FOR THE VENTRITEX TVL LEAD SYSTEM:TRANSVENOUS RIGHT VENTRICULAR LEAD MODELS RV-1101, RV01, AND RV02; TRANSVENOUS SUPERIOR VENA CAVA LEAD MODELS, SV-1101, SV01, SV02, AND SV03; SUBCUTANEOUS LEAD MODELS, SQ-701 AND SQ01; VEIN PICK MODEL TV-0001; SILICONE LUBRICANT MODEL TV-0013; LEAD TUNNELER KIT MODEL LTK-01; MODEL AC-2481 HIGH VOLTAGE Y-ADAPTER; MODEL AC-CDT-EX VENTRITEX EXTERNAL STIMULATOR ADAPTER; AND TVL LEAD SYSTEM ACCESSORY KIT
- Regulatory pathway
- Original PMA
- Clinical specialty
- Cardiovascular
- Decision date
- May 10, 1996
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P950022
- Regulatory pathway
- Premarket approval application
- Applicant
- ABBOTT MEDICAL
- Product code
- LWS
- Decision code
- APPR
- Decision date
- May 10, 1996
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Implantable cardioverter defibrillator (non-CRT).
- Applicant
- Abbott Medical
- Product code
- LWS
- FDA device class
- 3
The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.
FDA decision timeline
P950022 received
Application receipt date recorded by FDA.
P950022 · FDA decision
APPR
P950022/S153 · Related supplement
UltiSynq Defibrillation lead; SurGrip Suture Sleeve Accessory
Timeline entries are records held by MedtechLedger for P950022. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P950022
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| ABBOTT MEDICAL | PMA supplement | Nov 5, 2026 | FDA |
Explore the linked device profile
Other records with product code LWS
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Medtronic Cardiac Rhythm Disease Management | PMA supplement | Nov 4, 2026 | FDA | |
Cobalt MRI ICD, Cobalt XT MRI ICD, Crome MRI ICDP980016/S967 | Medtronic Cardiac Rhythm Disease Management | PMA supplement | Oct 29, 2026 | FDA |
| Biotronik, Inc. | PMA supplement | Oct 22, 2026 | FDA | |
| Biotronik, Inc. | PMA supplement | Oct 13, 2026 | FDA | |
| Biotronik, Inc. | PMA supplement | Oct 9, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Abbott Medical
- Headquarters
- Not reported
- Brand website
- abbott.com
- FDA applicant address
- 15900 Valley View Ct., Sylmar, CA, 91335
Sources and methodology
- Original FDA record: P950022
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records

